DK0976748T3 - Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet - Google Patents

Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet

Info

Publication number
DK0976748T3
DK0976748T3 DK98900741T DK98900741T DK0976748T3 DK 0976748 T3 DK0976748 T3 DK 0976748T3 DK 98900741 T DK98900741 T DK 98900741T DK 98900741 T DK98900741 T DK 98900741T DK 0976748 T3 DK0976748 T3 DK 0976748T3
Authority
DK
Denmark
Prior art keywords
phospholipase
inhibitory activity
optionally substituted
pyrrolidine derivatives
ch2nhco
Prior art date
Application number
DK98900741T
Other languages
Danish (da)
English (en)
Inventor
Kaoru Seno
Mitsuaki Ohtani
Fumihiko Watanabe
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of DK0976748T3 publication Critical patent/DK0976748T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
DK98900741T 1997-01-31 1998-01-27 Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet DK0976748T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1796297 1997-01-31
PCT/JP1998/000307 WO1998033797A1 (fr) 1997-01-31 1998-01-27 Derives de pyrrolidine ayant une activite inhibant la phospholipase a2

Publications (1)

Publication Number Publication Date
DK0976748T3 true DK0976748T3 (da) 2004-03-22

Family

ID=11958379

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98900741T DK0976748T3 (da) 1997-01-31 1998-01-27 Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet

Country Status (20)

Country Link
US (1) US6147100A (ja)
EP (1) EP0976748B1 (ja)
JP (1) JP3850450B2 (ja)
KR (1) KR100354358B1 (ja)
CN (1) CN1217942C (ja)
AT (1) ATE255579T1 (ja)
AU (1) AU719210B2 (ja)
BR (1) BR9807132A (ja)
CA (1) CA2277947C (ja)
DE (1) DE69820248T2 (ja)
DK (1) DK0976748T3 (ja)
ES (1) ES2210710T3 (ja)
HU (1) HUP0000965A3 (ja)
NO (1) NO313881B1 (ja)
PL (1) PL334915A1 (ja)
PT (1) PT976748E (ja)
RU (1) RU2198174C2 (ja)
TR (1) TR199901847T2 (ja)
TW (1) TW577875B (ja)
WO (1) WO1998033797A1 (ja)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7291626B1 (en) 1998-04-09 2007-11-06 John Hopkins University School Of Medicine Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
AU6023300A (en) * 1999-07-26 2001-02-13 Shionogi & Co., Ltd. Drug compositions exhibiting thrombopoietin agonism
ATE328002T1 (de) 1999-10-13 2006-06-15 Univ Johns Hopkins Med Verbindungen zur regulierung des hedgehog- signalwegs, zusammensetzungen und verwendungen davon
CA2388468C (en) * 1999-10-14 2011-01-25 Curis, Inc. Mediators of hedgehog signalling pathways, compositions and uses related thereto
US6552016B1 (en) 1999-10-14 2003-04-22 Curis, Inc. Mediators of hedgehog signaling pathways, compositions and uses related thereto
CA2388479A1 (en) * 1999-10-22 2001-05-03 Shionogi & Co., Ltd. Preventives or remedies for arrhythmia
US7361663B2 (en) 1999-11-10 2008-04-22 Aventis Pharmaceuticals Inc. N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa
DE60036568T2 (de) * 1999-11-10 2008-06-26 Sanofi-Aventis Deutschland Gmbh N-acylpyrrolidin-2-ylalkylbenzamidin-derivate als inhibitoren von factor xa
EP1309756B1 (en) * 2000-08-07 2012-06-13 Akzo Nobel N.V. Process for sizing paper
CA2435143A1 (en) * 2001-01-26 2002-08-01 Shionogi & Co., Ltd. Halogen compounds having thrombopoietin receptor agonism
US20030073945A1 (en) * 2001-10-17 2003-04-17 Liang-Kuang Diang Ozone hemodiafiltration device
US6867320B2 (en) * 2002-02-21 2005-03-15 Asahi Kasei Pharma Corporation Substituted phenylalkanoic acid derivatives and use thereof
WO2003101177A2 (en) * 2002-06-04 2003-12-11 Sequenom, Inc. Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions
AUPS282602A0 (en) 2002-06-07 2002-06-27 Garvan Institute Of Medical Research Method of inhibiting cell proliferation
US20050239077A1 (en) * 2002-06-27 2005-10-27 Adam Gail I R Diagnosing predisposition to fat deposition and associated conditions
EP1581095A4 (en) * 2002-06-27 2006-10-18 Harkness Pharmaceuticals Inc THERAPEUTIC METHODS FOR REDUCING FAT DEPOSIT AND TREATING THE DISEASES THEREOF
EP1597255A1 (en) * 2002-11-13 2005-11-23 Rigel Pharmaceuticals, Inc. Rhodanine derivatives and pharmaceutical compositions containing them
JPWO2004050654A1 (ja) * 2002-11-29 2006-03-30 塩野義製薬株式会社 ピロリジン化合物の合成とその塩
US7781464B2 (en) * 2003-01-17 2010-08-24 Bexel Pharmaceuticals, Inc. Heterocyclic diphenyl ethers
US7521465B2 (en) * 2003-01-17 2009-04-21 Bexel Pharmaceuticals, Inc. Diphenyl ether derivatives
US6794401B2 (en) * 2003-01-17 2004-09-21 Bexel Pharmaceuticals, Inc. Amino acid phenoxy ethers
DE10305089A1 (de) * 2003-02-07 2004-08-26 Merckle Gmbh Neue heteroarylsubstituierte Acetonderivate als Hemmstoffe der Phospholiphase A2
TW200503698A (en) * 2003-04-08 2005-02-01 Shionogi & Co Composition for treating or preventing dermatitis
JP2007528362A (ja) 2003-08-14 2007-10-11 旭化成ファーマ株式会社 置換アリールアルカン酸誘導体及びその用途
US7087576B2 (en) * 2003-10-07 2006-08-08 Bexel Pharmaceuticals, Inc. Dipeptide phenyl ethers
US7207652B2 (en) * 2003-10-17 2007-04-24 Lexmark International, Inc. Balanced satellite distributions
US20090215857A1 (en) * 2005-09-13 2009-08-27 Pfizer Products Inc. Therapeutic Pyrrolidines
TWI461423B (zh) * 2008-07-02 2014-11-21 Astrazeneca Ab 用於治療Pim激酶相關病狀及疾病之噻唑啶二酮化合物
AU2009307918A1 (en) * 2008-10-21 2010-04-29 Merck Sharp & Dohme Corp. 2,4-disubstituted pyrrolidine orexin receptor antagonists
KR101931628B1 (ko) 2010-06-18 2019-03-13 화이트헤드 인스티튜트 포 바이오메디칼 리서치 항바이러스 화합물에 대한 타켓인 pla2g16
US8772277B2 (en) 2011-08-04 2014-07-08 Takeda Pharmaceutical Company Limited Nitrogen-containing heterocyclic compound
USD804651S1 (en) 2017-01-10 2017-12-05 Howard Loonan Syringe

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2826379B2 (ja) * 1990-01-22 1998-11-18 三共株式会社 チアゾリジン誘導体を有効成分とする肥満性高血圧症治療剤
FR2680512B1 (fr) * 1991-08-20 1995-01-20 Adir Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5317016A (en) * 1991-08-20 1994-05-31 Shionogi Seiyaku Kabushiki Kaisha Pyrrolidylthiocarbapenem derivative
JPH05306224A (ja) * 1992-04-24 1993-11-19 Wakamoto Pharmaceut Co Ltd ドーパミン β−ヒドロキシラーゼ阻害剤
EP0586229A1 (en) * 1992-09-01 1994-03-09 Zeneca Limited 3-Hydroxy-3-(subst-akyl)-pyrrolidines as 5-lipoxygenase inhibitors
TW245716B (ja) * 1992-12-28 1995-04-21 Takeda Pharm Industry Co
AU684316B2 (en) * 1993-10-15 1997-12-11 Shionogi & Co., Ltd. Oxazolinone derivative having intracellular phospholipase A2 inhibitor activity
JPH07138258A (ja) * 1993-11-16 1995-05-30 Taiho Yakuhin Kogyo Kk チアゾリジンジオン誘導体又はその塩
NO303782B1 (no) * 1994-03-23 1998-08-31 Sankyo Co Tiazolidin- og oksazolidinderivater og farmas°ytiske preparater inneholdende slike, samt deres anvendelse til fremstilling av medikamenter
PT848004E (pt) * 1995-07-31 2003-07-31 Shionogi & Co Derivados pirrolidina tendo actividade inibidora da fosfolipase a2
JPH09176162A (ja) * 1995-12-22 1997-07-08 Toubishi Yakuhin Kogyo Kk チアゾリジンジオン誘導体及びその製造法並びにそれを含む医薬組成物
CN1221417A (zh) * 1996-07-26 1999-06-30 雷迪博士研究基金会 具有抗糖尿病、降低血脂、抗高血压性能的噻唑烷二酮化合物,其制备方法及其药物组合物
EP0894089B9 (en) * 1997-05-02 2003-04-02 Dr. Reddy's Laboratories Ltd. Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
JP2001518069A (ja) * 1997-05-02 2001-10-09 ドクター・レディーズ・リサーチ・ファウンデーション 低脂質性、抗高血圧性特性を有する新規な抗糖尿病化合物、それらの製造方法及びそれらを含有する薬学的組成物

Also Published As

Publication number Publication date
BR9807132A (pt) 2000-01-25
KR20000070497A (ko) 2000-11-25
PT976748E (pt) 2004-03-31
KR100354358B1 (ko) 2002-09-28
AU719210B2 (en) 2000-05-04
HUP0000965A2 (hu) 2001-04-28
WO1998033797A1 (fr) 1998-08-06
EP0976748A1 (en) 2000-02-02
ES2210710T3 (es) 2004-07-01
RU2198174C2 (ru) 2003-02-10
NO993706L (no) 1999-09-30
EP0976748A4 (en) 2001-08-08
TW577875B (en) 2004-03-01
ATE255579T1 (de) 2003-12-15
DE69820248T2 (de) 2004-09-23
US6147100A (en) 2000-11-14
CA2277947A1 (en) 1998-08-06
NO993706D0 (no) 1999-07-29
NO313881B1 (no) 2002-12-16
CN1217942C (zh) 2005-09-07
HUP0000965A3 (en) 2001-11-28
JP3850450B2 (ja) 2006-11-29
PL334915A1 (en) 2000-03-27
CN1251587A (zh) 2000-04-26
AU5577598A (en) 1998-08-25
TR199901847T2 (xx) 2000-06-21
DE69820248D1 (de) 2004-01-15
CA2277947C (en) 2004-09-21
EP0976748B1 (en) 2003-12-03

Similar Documents

Publication Publication Date Title
DK0976748T3 (da) Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet
ES2182852T3 (es) Derivados de prolinamida.
PT705833E (pt) Derivado de dc-89
HK1032969A1 (en) Novel pyridazine derivatives and drugs containing the same as the active ingredient
CA2311742A1 (en) 6-amino-9-benzyl-8-hydroxypurine derivatives
DK260588A (da) Heterocykliske ketoner
DK0641770T3 (da) Hidtil ukendte forbindelser med blodpladeaggegationsinhiberende aktivitet
ATE223411T1 (de) 1-methylcarbapenem-derivate
ATE174593T1 (de) Neue bisoxadiazolidinderivate
FI952420A (fi) Glukopyranosidibentsotiofeenit
DE60238847D1 (de) Pyrimidinderivate enthaltendes medikament
ES2149180T3 (es) Derivado de pirazolotiazolopirimidina.